RET fusions have been described in up to one-third of papillary thyroid cancers and in 2% of lung adenocarcinoma cases; CCDC6-RET and NCOA4-RET are the most commonly identified RET fusions [22, 23]. The gene discussed is CCDC6; the disease is lung adenocarcinoma.